Shockwave Medical Revenue and Competitors
Estimated Revenue & Valuation
- Shockwave Medical's estimated annual revenue is currently $175.7M per year.
- Shockwave Medical received $35.0M in venture funding in October 2017.
- Shockwave Medical's estimated revenue per employee is $188,903
- Shockwave Medical's total funding is $147.5M.
- Shockwave Medical's current valuation is $5.9B. (January 2022)
Employee Data
- Shockwave Medical has 930 Employees.
- Shockwave Medical grew their employee count by 22% last year.
Shockwave Medical's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and Consultant | Reveal Email/Phone |
2 | Area VP | Reveal Email/Phone |
3 | Sr. VP Clinical Affairs | Reveal Email/Phone |
4 | Area VP | Reveal Email/Phone |
5 | Area VP Sales | Reveal Email/Phone |
6 | General Manager / VP Operations - Costa Rica | Reveal Email/Phone |
7 | Chief Financial Officer | Reveal Email/Phone |
8 | Area VP | Reveal Email/Phone |
9 | Area VP - Western US | Reveal Email/Phone |
10 | Associate Chief Medical Officer | Reveal Email/Phone |
Shockwave Medical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Shockwave Medical?
Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotrispy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. In peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, IVL demonstrated safety and consistent procedure success with low procedural complications. The technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatments. And because it is built on a traditional balloon catheter platform, it integrates seamlessly with clinicians existing workflow. Stay connected with us at www.ShockwaveMedical.com and on Twitter @ShockwaveIVL ISI- bit.ly/2x9TiR4
keywords:Biotechnology,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals$147.5M
Total Funding
930
Number of Employees
$175.7M
Revenue (est)
22%
Employee Growth %
$5.9B
Valuation
N/A
Accelerator
Shockwave Medical News
ShockWave Medical, Inc, a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the...
ShockWave Medical, Inc, a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the...
Shockwave aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through...
Shockwave Medical (NSDQ:SWAV) has won breakthrough device designation from the FDA for the sonic pressure-wave system it has developed to treat calcified coronary lesions. The Santa Clara, Calif.-based company’s C2 IVL (intravascular lithotripsy) catheter is designed to improve blood flow to th ...
Shockwave Medical, a Fremont, Calif.-based developer of a treatment of calcified cardiovascular disease, raised $35m in financing. This was an extension of the company’s previously announced $45m Series C financing. New investor Fidelity Management & Research Company participated, along with ce ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $360.7M | 937 | -4% | N/A |
#2 | $240.2M | 953 | N/A | N/A |
#3 | $377.7M | 981 | 7% | N/A |
#4 | $384.2M | 998 | -18% | N/A |
#5 | $227.6M | 1016 | 6% | N/A |
Shockwave Medical Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2015-05-22 | $40.0M | Undisclosed | Sofinnova Partners | Article |
2016-11-23 | $45.0M | C | Sectoral Asset Management | Article |
2017-10-11 | $35.0M | C | Fidelity Management & Research Company | Article |